Tag Archives: breast cancer treatment
SABCS 2019
by Karuna Jaggar, Executive Director
Every year we go to the San Antonio Breast Cancer Symposium (SABCS), the largest breast cancer conference in the world, so we can bring you updates and analysis of the latest breast cancer research and treatment.
It's impossible to... Read more
Posted in Articles
SABCS 2019: Tiny treatment updates via Tweet
Over a thousand papers are presented at the San Antonio Breast Cancer Symposium each year, and I attend more than 12 hours of presentations and discussions each day. It’s a lot to cover and I try to focus on the results that are most relevant and interesting to our... Read more
Posted in Articles
SABCS 2019: Mixed Results for Hormone Replacement Therapy and Breast Cancer Risk
by Karuna Jaggar, Executive Director
A large, federally-funded study evaluating the use of hormone replacement therapy (HRT) to reduce the risk of heart disease, bone loss, and other effects of menopause was stopped early in 2002 when researchers found more breast cancers... Read more
Posted in Articles
SABCS 2019: Less Surgery, But Still Some, For Breast Cancer
by Karuna Jaggar, Executive Director
When first diagnosed with cancer, it can feel like the surest, fastest way to get rid of it is to cut it out. So many newly diagnosed breast cancer patients are surprised to learn that surgery isn’t the first step in treatment for many... Read more
Posted in Articles
SABCS 2019: No Winners in Debate Over Treatment Options
by Karuna Jaggar, Executive Director
Friday morning, SABCS opened with a debate that was hyped like a sporting event in an effort to spice up a pretty dry conference. The topic was about surgical options, which is a defining decision for a majority of people diagnosed with... Read more
Posted in Articles
SABCS 2019: Evaluating—and understanding—breast cancer studies at SABCS
By Karuna Jaggar, Executive Director
For 42 years, breast cancer researchers and doctors have been gathering in San Antonio... Read more
Posted in Articles
SABCS 2019: T-DM1 tradeoffs: not worth the costs and side effects in early stage breast cancer
Just because there is an FDA approved treatment, should it be offered to everyone?
Dr Tolaney from the Dana Farber Cancer Institute presented data (GS1-05) exploring whether it’s appropriate to use the monoclonal antibody T-DM1 to treat early stage HER2+ breast cancer. Even... Read more
Posted in Articles
SABCS 2019: Good News and Unicorns on Day 1 of SABCS
by Karuna Jaggar, Executive Director
I feel like I saw unicorn today.
I began Day 1 of the San Antonio Breast Cancer Symposium with this tweet:
“Back for my 8th tour of breast cancer research at #SABCS19. Here’s what I’m 'still' looking for:
... Read more
Posted in Articles
a project of Breast Cancer Action